An increase in cardiac alpha1-adrenoceptors following chronic clonidine treatment

Shizuo Yamada, Henry I. Yamamura, William R Roeske

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Chronic treatment (22 days) of rats with clonidine (0.5 mg/kg s.c. twice a day followed by 20 h of withdrawal) resulted in a significant increase in the specific [3H]WB4101 binding to ventricular and intraventricular septal α1-adrenoceptors but no alteration of the atrial α1-adrenoceptors. Scatchard analysis indicated that the increase in the [3H]WB4101 binding to the clonidine-treated cardiac tissues was due to an enhancement of the α1-adrenoceptor density since there was a significant increase in the Bmax value for the [3H]WB4101 binding to the treated ventricles without a change in the Kd value. The specific [3H]WB4101 binding to cardiac α1-adrenoceptors was not altered by the acute (1 day) or 7 days treatment with clonidine. Chronic treatment with clonidine had no significant effect on the specific [3H](-)DHA binding to the atrial and ventricular β-adrenoceptors. The noradrenaline (NA) concentrations in the clonidine-treated ventricles and intraventricular septae were decreased by 16-20%. These data provide biochemical evidence compatible with a significant reduction of sympathetic outflow to the ventricular myocardium by clonidine.

Original languageEnglish (US)
Pages (from-to)115-118
Number of pages4
JournalNaunyn-Schmiedeberg's Archives of Pharmacology
Volume320
Issue number2
DOIs
StatePublished - Aug 1982

Fingerprint

Clonidine
Adrenergic Receptors
Myocardium
Norepinephrine
(2-(2',6'-dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane

Keywords

  • [H]WB4101 binding
  • Cardiac α-adrenoceptor
  • Chronic clonidine treatment
  • Noradrenaline concentrations
  • Withdrawal syndromes

ASJC Scopus subject areas

  • Pharmacology

Cite this

An increase in cardiac alpha1-adrenoceptors following chronic clonidine treatment. / Yamada, Shizuo; Yamamura, Henry I.; Roeske, William R.

In: Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 320, No. 2, 08.1982, p. 115-118.

Research output: Contribution to journalArticle

@article{d92ae043983943a9b41be7bc5eab3d9a,
title = "An increase in cardiac alpha1-adrenoceptors following chronic clonidine treatment",
abstract = "Chronic treatment (22 days) of rats with clonidine (0.5 mg/kg s.c. twice a day followed by 20 h of withdrawal) resulted in a significant increase in the specific [3H]WB4101 binding to ventricular and intraventricular septal α1-adrenoceptors but no alteration of the atrial α1-adrenoceptors. Scatchard analysis indicated that the increase in the [3H]WB4101 binding to the clonidine-treated cardiac tissues was due to an enhancement of the α1-adrenoceptor density since there was a significant increase in the Bmax value for the [3H]WB4101 binding to the treated ventricles without a change in the Kd value. The specific [3H]WB4101 binding to cardiac α1-adrenoceptors was not altered by the acute (1 day) or 7 days treatment with clonidine. Chronic treatment with clonidine had no significant effect on the specific [3H](-)DHA binding to the atrial and ventricular β-adrenoceptors. The noradrenaline (NA) concentrations in the clonidine-treated ventricles and intraventricular septae were decreased by 16-20{\%}. These data provide biochemical evidence compatible with a significant reduction of sympathetic outflow to the ventricular myocardium by clonidine.",
keywords = "[H]WB4101 binding, Cardiac α-adrenoceptor, Chronic clonidine treatment, Noradrenaline concentrations, Withdrawal syndromes",
author = "Shizuo Yamada and Yamamura, {Henry I.} and Roeske, {William R}",
year = "1982",
month = "8",
doi = "10.1007/BF00506311",
language = "English (US)",
volume = "320",
pages = "115--118",
journal = "Naunyn-Schmiedeberg's Archives of Pharmacology",
issn = "0028-1298",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - An increase in cardiac alpha1-adrenoceptors following chronic clonidine treatment

AU - Yamada, Shizuo

AU - Yamamura, Henry I.

AU - Roeske, William R

PY - 1982/8

Y1 - 1982/8

N2 - Chronic treatment (22 days) of rats with clonidine (0.5 mg/kg s.c. twice a day followed by 20 h of withdrawal) resulted in a significant increase in the specific [3H]WB4101 binding to ventricular and intraventricular septal α1-adrenoceptors but no alteration of the atrial α1-adrenoceptors. Scatchard analysis indicated that the increase in the [3H]WB4101 binding to the clonidine-treated cardiac tissues was due to an enhancement of the α1-adrenoceptor density since there was a significant increase in the Bmax value for the [3H]WB4101 binding to the treated ventricles without a change in the Kd value. The specific [3H]WB4101 binding to cardiac α1-adrenoceptors was not altered by the acute (1 day) or 7 days treatment with clonidine. Chronic treatment with clonidine had no significant effect on the specific [3H](-)DHA binding to the atrial and ventricular β-adrenoceptors. The noradrenaline (NA) concentrations in the clonidine-treated ventricles and intraventricular septae were decreased by 16-20%. These data provide biochemical evidence compatible with a significant reduction of sympathetic outflow to the ventricular myocardium by clonidine.

AB - Chronic treatment (22 days) of rats with clonidine (0.5 mg/kg s.c. twice a day followed by 20 h of withdrawal) resulted in a significant increase in the specific [3H]WB4101 binding to ventricular and intraventricular septal α1-adrenoceptors but no alteration of the atrial α1-adrenoceptors. Scatchard analysis indicated that the increase in the [3H]WB4101 binding to the clonidine-treated cardiac tissues was due to an enhancement of the α1-adrenoceptor density since there was a significant increase in the Bmax value for the [3H]WB4101 binding to the treated ventricles without a change in the Kd value. The specific [3H]WB4101 binding to cardiac α1-adrenoceptors was not altered by the acute (1 day) or 7 days treatment with clonidine. Chronic treatment with clonidine had no significant effect on the specific [3H](-)DHA binding to the atrial and ventricular β-adrenoceptors. The noradrenaline (NA) concentrations in the clonidine-treated ventricles and intraventricular septae were decreased by 16-20%. These data provide biochemical evidence compatible with a significant reduction of sympathetic outflow to the ventricular myocardium by clonidine.

KW - [H]WB4101 binding

KW - Cardiac α-adrenoceptor

KW - Chronic clonidine treatment

KW - Noradrenaline concentrations

KW - Withdrawal syndromes

UR - http://www.scopus.com/inward/record.url?scp=0019988942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019988942&partnerID=8YFLogxK

U2 - 10.1007/BF00506311

DO - 10.1007/BF00506311

M3 - Article

C2 - 6289138

AN - SCOPUS:0019988942

VL - 320

SP - 115

EP - 118

JO - Naunyn-Schmiedeberg's Archives of Pharmacology

JF - Naunyn-Schmiedeberg's Archives of Pharmacology

SN - 0028-1298

IS - 2

ER -